Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-11-27

FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)

View source ↗

Summary

FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead, indicating a change to the product la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

SUPPL AP for TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)